Macular Edema clinical trials at UCSD
2 research studies open to eligible people
Showing trials for
Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
open to eligible people ages 18 years and up
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
La Jolla, California and other locations
Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
open to eligible people ages 18 years and up
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)
La Jolla, California and other locations
Last updated: